MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Jeffrey F. Eisenberg, its Executive Vice President and Interim Chief Executive Officer, is scheduled to provide an update on Noven’s business and prospects at the Raymond James 29th Annual Institutional Investors Conference in Orlando on Monday, March 3, 2008, at 10:25 a.m. Eastern Time. The public is invited to listen to the presentation live via webcast at www.noven.com, and a replay will be available for at least two weeks at the same site.
